Proliferative Primary Human Sertoli Cell Cultures And Their Applications

Abstract

Technology for the isolation and propagation of primary human Sertoli cells from normal testes tissue, including cultures of proliferative primary human Sertoli cells for research and clinical applications, and a pharmaceutical composition for cell therapy, ex vivo gene therapy, and for the reduction of autoimmune, allograft, and xenograft immune reactions.

Description

TECHNICAL FIELD[0001]The Sertoli cell creates the blood-testis barrier in the seminiferous tubules of the testes, and is critical for the production of viable, haploid sperm. Sertoli cells are among several types of cells that have specialized capability to ward off the immune system and that therefore have been termed “immune-privileged”. Sertoli cells also have other characteristics that make them potentially valuable for various types of cell therapies. The present invention consists of technology for the isolation of proliferative Sertoli cells from human testis tissue and for their propagation for applications in cell and gene therapy and for research in reproductive health and other areas. Using this technology, human Sertoli cell that have the ability to proliferate in cell culture can be isolated from testis tissue, and can be frozen, thawed and continue to proliferate upon further culture after thawing. The method described enables the isolation of primary human Sertoli cel...

AI Technical Summary

Benefits of technology

[0026]The present invention relates to the surprising discovery of methodology enabling the isolation of a small number of primary Sertoli cells from adult human testicular tissue that proliferate and can be passaged in vitro enabling expansion of the population. With this methodology, few Sertoli cells are detected adhering to the culture dish even 2-10 days post-isolation and, thus, the isolated cells must represent only a small percentage of the Sertoli cells in the testes that in adult men that number approximately 4 billion (Johnson, Zane et al. 1984; Cortes, Muller et al. 1987). Despite the isolation of only a few viable primary Sertoli cells, these proliferate until becoming confluent. The population can be greatly expanded by continuously passaging the cells for months such that the Sertoli cells that can be produced from a single donor are more than would be expected to be obtained originally from 10-20 individuals. This technology enables for the first time the production of a large number of primary human Sertoli cells from a single donor that will be suitable for a number of research and therapeutic applications.

Problems solved by technology

However, neonatal porcine Sertoli cells did not protect porcine islets from immune rejection in nonimmunosuppressed diabetic rats (Wang, Skinner et al.

But a ready supply of primary human Sertoli cells has not been available previously.

One of the significant hurdles in their application is that according to some reports allogeneic embryonic stem cells will be subject to immune rejection when differentiated (Ponsaerts, van Tendeloo et al.

Lack of availability of primary human Sertoli cells has limited the opportunity to study their characteristics and functionality, and to develop human Sertoli-cell based cell therapies and co-transplantation protocols.

However, the prior art is deficient in teaching a method or providing a source of human Sertoli cells that proliferate in culture and that therefore could serve as a source of Sertoli cells for various types of clinical applications and for analysis of the function and characteristics of human Sertoli cells.

Development of an effective, consumer-friendly contraceptive for men remains challenging (Matthiesson and McLachlan 2006).

Images